Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA's Off-Label Communication Changes Should Start With Payers – PhRMA

Executive Summary

PhRMA Senior Counsel Jeffrey Francer offers three-step reform approach to loosening FDA’s restrictions, beginning with the 'low-hanging fruit' of talking with payers.


Related Content

FDA Soliciting Broad Range Of Comments From Industry On Regulatory Reform
Payer Communications Safe Harbor Should Extend To Off-Label Uses – Industry
'Safe Harbor' For Preapproval Information Exchange To Get Legislative Push
Off-Label Promotion: 'Safe Harbor' Preferable To Expansive Free Speech Rulings
Payers Want Access To US FDA's Pre-Submission Meetings
Trump, Congress And The Future Of Value-Based Drug Contracting
Off-Label Debate Between FDA, Industry To Formally Begin After Election
Off-Label Communication Principles From PhRMA, BIO Aim For Reg Changes
FDA To Join The 'Real World' Under PDUFA VI
Comparative Rx Economic Claims Without Head-to-Head Trials Risky – J&J’s Jimenez


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts